Welcome to our dedicated page for Ambev SEC filings (Ticker: ABEV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambev S.A. (ABEV) SEC filings page brings together the company’s disclosures as a foreign private issuer with securities listed on the New York Stock Exchange. Ambev files an annual report on Form 20-F, as highlighted in multiple press releases announcing the availability of its annual reports for successive years. These 20-F filings contain the company’s complete audited financial statements, and the press releases note that American Depositary Receipt holders may request hard copies free of charge.
In addition to its annual reports, Ambev regularly furnishes Form 6-K current reports. The examples provided include notices to shareholders about ordinary shareholders’ meetings, extracts of minutes from Board of Directors meetings, and detailed explanations of decisions to distribute dividends and interest on capital based on extraordinary balance sheets. Other 6-Ks disclose policies on executive remuneration and the grant of stock options and restricted shares, as well as a policy on hiring services related or not related to auditing, which sets conditions for engaging independent auditors and lists non-authorized services to preserve auditor independence.
Ambev also uses Form 6-K to report related party transactions, such as its agreement with its controlling shareholder Anheuser-Busch InBev SA/NV for the use of the BEES B2B digital platform, and to provide consolidated and individual forms under Article 11 of CVM Instruction 358/2002 that detail management and related persons’ transactions in Ambev shares and ADRs. These forms show initial and final positions, deliveries of restricted shares, purchases, and sales.
On Stock Titan, these filings can be paired with AI-powered summaries that explain the key points of lengthy documents, highlight items such as dividend approvals, interest on capital distributions, insider share movements, and policy changes, and help readers navigate Ambev’s 20-F and 6-K disclosures more efficiently.
AMBEV S.A. executive Parolari Guilherme Fleury de Figueiredo Ferraz filed an initial ownership report showing direct holdings in common and equity awards. He holds 19,893 common shares and 168,353 restricted shares that vest on December 1, 2028, each representing a right to receive one common share minus withholding taxes.
He also holds stock options over 67,658 common shares at an exercise price of 3.2600 expiring on December 2, 2026, 233,781 shares at 3.1100 expiring on December 23, 2026, 80,393 shares at 3.9100 expiring on December 2, 2027, and 103,453 shares at 3.2200 expiring on December 4, 2028. The filing reflects existing holdings rather than new market purchases or sales.
AMBEV S.A. director Luciana Pires Dias filed an initial ownership report showing awards of restricted shares tied to common shares and a small direct common share position. She holds restricted shares representing 38,689 common shares vesting on December 1, 2028, 39,505 vesting on December 2, 2029, and 33,289 vesting on December 1, 2030. She also directly owns 3,000 common shares. Each restricted share gives a contingent right to receive one common share, reduced by withholding taxes.
AMBEV S.A. director Milton Seligman filed an initial Form 3 reporting his equity holdings in the company. He directly owns 545,090 common shares and holds several grants of restricted shares that each represent a contingent right to receive one common share, minus withholding taxes, upon vesting.
The filing also lists stock options giving him the right to buy 52,949 common shares at an exercise price of 3.2200 per share exercisable until December 4, 2028, and 72,370 common shares at 3.4300 per share exercisable until December 3, 2029. Restricted share awards vest on dates ranging from December 1, 2026 through December 1, 2030.
AMBEV S.A. director Marcos de Barros Lisboa filed a Form 3 reporting his initial holdings. He directly owns 20,115 common shares, several blocks of restricted shares that vest between December 1, 2026 and December 1, 2030, and stock options on 43,169, 40,064, 52,949 and 72,370 common shares with exercise prices between $3.22 and $3.91 expiring from December 2, 2026 through December 3, 2029. The restricted shares each represent a contingent right to receive one common share, net of withholding taxes.
AMBEV S.A. director Michel D. Doukeris filed an initial insider ownership report on Form 3. The filing identifies him as a director of the company but does not list any insider transactions or derivative positions at this time.
AMBEV S.A. officer Malik Parente Guilherme filed an initial Form 3 showing existing equity interests in the company. The report lists direct holdings of Common Shares as well as several blocks of Restricted Shares, each representing a right to receive one common share minus withholding taxes.
Restricted share grants include awards tied to December 1, 2026, March 1, 2027, December 2, 2027, February 28, 2028 and December 1, 2028 vesting dates. The filing also shows multiple stock option positions over common shares with exercise prices between 3.26 and 3.91 and expirations from March 31, 2026 through December 3, 2029. No new purchases or sales are reported; it is a snapshot of current holdings.
AMBEV S.A. director Fernando Tennenbaum filed a Form 3 reporting his holdings of stock options on the company’s common shares. The data shows stock options with rights to buy 205,698 shares at an exercise price of 3.2200 per share, expiring on December 4, 2028, and additional options over 253,317 shares at an exercise price of 3.4300, expiring on December 3, 2029. All positions are reported as held directly.
AMBEV S.A. director Moreira Ricardo Manuel Frangatos Pires filed an initial ownership report showing beneficial ownership of 3,468,040 common shares, held directly. The total includes certain common shares represented by American Depositary Shares, each ADS corresponding to one common share.
AMBEV S.A. director Fabio Colletti Barbosa has filed an initial ownership report showing multiple grants of restricted shares. Each restricted share represents a contingent right to receive one common share, minus withholding taxes, with vesting dates on December 1, 2026, December 1, 2027, December 1, 2028, December 2, 2029 and December 1, 2030. The filing lists these holdings as directly owned and does not show any buys or sells.